This Black History Month, we’re centering the voices, stories, and experiences of Black lupus warriors. Throughout February, we’re sharing resources and community spaces designed to support and ...

The U.S. Food and Drug Administration (FDA) issued a complete response letter requesting additional information from ...

Congress has taken the final steps in the FY 2026 budget process, passing legislation that increases funding for lupus programs, including $27 million - the most in history - for lupus programs at the ...

A new study exploring the investigational therapy, Zorpo-cel, met its primary safety and secondary efficacy endpoints in ...

Learn more about how your company or organization can raise its profile and morale by becoming a corporate partner.

Black History Month serves as a reminder to actively amplify Black voices, share stories and raise awareness throughout the ...

The U.S. Food and Drug Administration (FDA) approved Gazyva® to treat adults with lupus nephritis in October 2025. Gazyva targets and removes harmful B cells to help protect the kidneys in people with ...

Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug therapy, nipocalimab, met its primary endpoint and multiple key secondary ...

A new groundbreaking study has recently identified the link between the long-standing mystery in autoimmune disease: Epstein-Barr Virus (EBV) and how it contributes towards the development of systemic ...

The physical, emotional and financial toll of lupus can be invisible to those who don’t live with this disease. Lupus symptoms affect each person differently, and it can be difficult for those without ...

Wondering if you have lupus or receiving a diagnosis of lupus can be challenging and stressful. We have put together some resources to help you find the support and information that you need. Our ...